These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17911401)

  • 1. Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor.
    Renlund N; O'Neill FH; Zhang L; Sidis Y; Teixeira J
    J Endocrinol; 2007 Oct; 195(1):95-103. PubMed ID: 17911401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.
    Wu X; Zhang N; Lee MM
    Endocrinology; 2012 Oct; 153(10):4929-37. PubMed ID: 22872577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
    Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.
    Visser JA; Olaso R; Verhoef-Post M; Kramer P; Themmen AP; Ingraham HA
    Mol Endocrinol; 2001 Jun; 15(6):936-45. PubMed ID: 11376112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling.
    Xie C; Jiang W; Lacroix JJ; Luo Y; Hao J
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells.
    Rejon CA; Hancock MA; Li YN; Thompson TB; Hébert TE; Bernard DJ
    Cell Signal; 2013 Dec; 25(12):2717-26. PubMed ID: 24018044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
    Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
    Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
    Olsen OE; Sankar M; Elsaadi S; Hella H; Buene G; Darvekar SR; Misund K; Katagiri T; Knaus P; Holien T
    J Cell Sci; 2018 Jun; 131(11):. PubMed ID: 29739878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
    Liu X; Nagarajan RP; Vale W; Chen Y
    FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoproteins affect endothelial BMP-signaling by modulating expression of the activin-like kinase receptor 1 and 2.
    Yao Y; Shao ES; Jumabay M; Shahbazian A; Ji S; Boström KI
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2266-74. PubMed ID: 18948634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival.
    Chauvin M; Garambois V; Choblet S; Colombo PE; Chentouf M; Gros L; De Brauwere DP; Duonor-Cerutti M; Dumas K; Robert B; Jarlier M; Martineau P; Navarro-Teulon I; Pépin D; Chardès T; Pèlegrin A
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation.
    Desgrosellier JS; Mundell NA; McDonnell MA; Moses HL; Barnett JV
    Dev Biol; 2005 Apr; 280(1):201-10. PubMed ID: 15766759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activins and inhibins and their signaling.
    Vale W; Wiater E; Gray P; Harrison C; Bilezikjian L; Choe S
    Ann N Y Acad Sci; 2004 Dec; 1038():142-7. PubMed ID: 15838109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin stimulates CYP19A gene expression in human ovarian granulosa cell-like KGN cells via the Smad2 signaling pathway.
    Nomura M; Sakamoto R; Morinaga H; Wang L; Mukasa C; Takayanagi R
    Biochem Biophys Res Commun; 2013 Jul; 436(3):443-8. PubMed ID: 23747729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
    Macías-Silva M; Hoodless PA; Tang SJ; Buchwald M; Wrana JL
    J Biol Chem; 1998 Oct; 273(40):25628-36. PubMed ID: 9748228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of steroidogenesis in Leydig cells by Müllerian-inhibiting substance.
    Fynn-Thompson E; Cheng H; Teixeira J
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):99-104. PubMed ID: 14656482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer.
    Basal E; Ayeni T; Zhang Q; Langstraat C; Donahoe PK; Pepin D; Yin X; Leof E; Cliby W
    Curr Mol Med; 2016; 16(3):222-31. PubMed ID: 26917267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-type specific regulation of myostatin signaling.
    Kemaladewi DU; de Gorter DJ; Aartsma-Rus A; van Ommen GJ; ten Dijke P; 't Hoen PA; Hoogaars WM
    FASEB J; 2012 Apr; 26(4):1462-72. PubMed ID: 22202673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.